Viewing Study NCT06790303


Ignite Creation Date: 2025-12-24 @ 7:30 PM
Ignite Modification Date: 2025-12-26 @ 4:03 AM
Study NCT ID: NCT06790303
Status: TERMINATED
Last Update Posted: 2025-06-04
First Post: 2025-01-22
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Platform Trial of Novel Regimens Versus Standard of Care (SoC) in Participants With Non-small Cell Lung Cancer (NSCLC) - Sub-study 2
Sponsor: GlaxoSmithKline
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2021-03-04
Start Date Type: ACTUAL
Primary Completion Date: 2021-09-23
Primary Completion Date Type: ACTUAL
Completion Date: 2021-09-23
Completion Date Type: ACTUAL
First Submit Date: 2025-01-22
First Submit QC Date: None
Study First Post Date: 2025-01-24
Study First Post Date Type: ACTUAL
Results First Submit Date: 2025-04-11
Results First Submit QC Date: None
Results First Post Date: 2025-06-04
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-05-24
Last Update Post Date: 2025-06-04
Last Update Post Date Type: ACTUAL